$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Yervoy使用量多少?
2025-10-19 11:44:20
Check Details
曲美替尼治疗黑色素瘤的效果如何呢?
2025-10-19 11:44:20
Check Details
曲美替尼(Mekinist)中文版说明书
2025-10-19 11:44:20
Check Details
曲美替尼主要治哪些病?
2025-10-19 11:44:20
Check Details
曲美替尼对黑色素瘤有多大的效果呢?
2025-10-19 11:44:20
Check Details
曲美替尼的作用及功效
2025-10-19 11:44:20
Check Details
曲美替尼在中国上市的时间
2025-10-19 11:44:20
Check Details
曲美替尼在中国是什么时候上市的呢?
2025-10-19 11:44:20
Check Details
达拉非尼去哪才买的到?
2025-10-19 11:44:20
Check Details
达拉非尼治疗黑色素瘤的治疗效果如何?
2025-10-19 11:44:20
Check Details
达拉非尼获批的适应症有哪些?
2025-10-19 11:44:20
Check Details
达拉非尼怎么购买呢?
2025-10-19 11:44:20
Check Details
1
2
...
6517
6518
6519
6520
6521
6522
6523
...
10233
10234
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Post-Enzalutamide mCRPC: HRR/PARP, PSMA Radioligand, and Chemotherapy Sequencing
2
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
3
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
4
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
5
Bedaquiline for Drug-Resistant TB: 24-Week Regimen, Combination Duration, and When to Stop or Extend
6
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments
7
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
8
Bosutinib for Ph+ CML: Indications, Dosing Adjustments, and Hepatic/Renal Safety
9
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
10
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
11
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
12
AZA+VEN+IVO Triplet Therapy for Newly Diagnosed IDH1 AML: High Response Rates and Durable Efficacy